Biotech Startups
10,023 companies tagged Biotech, with their investors and founders.
0 investors
MAXONA Pharmaceuticals develops non-opioid pain treatment options for the U.S. market. The company is focused on expanding therapeutic alternatives in pain management.
0 investors
Maxymune is a pharmaceutical company developing treatments for immunological diseases, including a small-molecule LAT1 inhibitor program targeting overactive T-cells in autoimmune conditions and an improved formulation of mycophenolic acid intended to reduce gastrointestinal side effects. Its work spans drug discovery and formulation of immunosuppressive therapies for patients with immunological disorders.
0 investors
0 investors
0 investors
0 investors
MBQ Pharma develops precision therapeutics that target Rac and CDC42 GTPases for cancer, autoimmune, and fibrotic diseases, with a lead compound (MBQ-167) aimed at preventing and removing metastases. Its lead candidate is in a Phase 1 study, based on IP licensed from the University of Puerto Rico.
0 investors
MD Hyperbaric operates medically-supervised hyperbaric oxygen therapy (HBOT) centers nationwide, treating conditions including chronic wounds and neurological injuries by delivering oxygen in pressurized environments. The company serves patients seeking non-invasive therapeutic treatment for healing and recovery.
0 investors
0 investors
MDI Therapeutics is a pharmaceutical company developing small molecule therapies for fibrosis and fibroproliferative diseases, including MDI-2517, an inhibitor of plasminogen activator inhibitor 1 (PAI-1) currently in a Phase 1 clinical study. It operates in the biotech and drug development space.
0 investors
MDM Wound Ventures develops evidence-based wound care solutions, including products based on medicinal honey research, for clinicians treating homecare patients. It focuses on advancing wound healing with reduced patient pain.
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
Medical 21 develops the MAVERICS Graft, a synthetic regenerative vascular graft that lets surgeons perform complete cardiac bypass procedures without harvesting the patient's own blood vessels. The graft uses a nitinol scaffold and stimulates angiogenesis so the body forms an arterial-like vessel from the patient's own cells, targeting coronary bypass surgery.
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors